- Home
- VTYX vs DLNG Comparison
VTYX vs DLNG Comparison
Compare VTYX & DLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTYX
- DLNG
- Stock Information
- Founded
- VTYX 2018
- DLNG 2013
- Country
- VTYX United States
- DLNG Greece
- Employees
- VTYX N/A
- DLNG N/A
- Industry
- VTYX Medicinal Chemicals and Botanical Products
- DLNG Marine Transportation
- Sector
- VTYX Health Care
- DLNG Consumer Discretionary
- Exchange
- VTYX Nasdaq
- DLNG Nasdaq
- Market Cap
- VTYX 154.9M
- DLNG 137.4M
- IPO Year
- VTYX 2021
- DLNG 2013
- Fundamental
- Price
- VTYX $10.38
- DLNG $3.81
- Analyst Decision
- VTYX Strong Buy
- DLNG
- Analyst Count
- VTYX 5
- DLNG 0
- Target Price
- VTYX $14.60
- DLNG N/A
- AVG Volume (30 Days)
- VTYX 2.5M
- DLNG 45.7K
- Earning Date
- VTYX 11-06-2025
- DLNG 11-20-2025
- Dividend Yield
- VTYX N/A
- DLNG 5.28%
- EPS Growth
- VTYX N/A
- DLNG 30.14
- EPS
- VTYX N/A
- DLNG 1.29
- Revenue
- VTYX N/A
- DLNG $158,275,000.00
- Revenue This Year
- VTYX N/A
- DLNG N/A
- Revenue Next Year
- VTYX N/A
- DLNG $0.37
- P/E Ratio
- VTYX N/A
- DLNG $2.95
- Revenue Growth
- VTYX N/A
- DLNG 4.34
- 52 Week Low
- VTYX $0.78
- DLNG $3.18
- 52 Week High
- VTYX $10.47
- DLNG $5.65
- Technical
- Relative Strength Index (RSI)
- VTYX 74.09
- DLNG 66.01
- Support Level
- VTYX $8.90
- DLNG $3.70
- Resistance Level
- VTYX $10.02
- DLNG $3.84
- Average True Range (ATR)
- VTYX 0.78
- DLNG 0.09
- MACD
- VTYX -0.10
- DLNG 0.03
- Stochastic Oscillator
- VTYX 94.86
- DLNG 90.12
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.